Results for tag: "Baxdela"

Baxdela is a brand of antibiotics used to treat a variety of bacterial infections. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. Baxdela is a combination of two active ingredients, delafloxacin and avibactam, which work together to fight bacterial infections. Baxdela is available in both oral and intravenous formulations, making it a versatile treatment option for a variety of bacterial infections. Baxdela is used to treat skin and soft tissue infections, as well as complicated urinary tract infections. It is also used to treat infections caused by multi-drug resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). Baxdela is generally well-tolerated and has a low risk of side effects. The Baxdela market is a rapidly growing segment of the antibiotics market. It is driven by the increasing prevalence of multi-drug resistant bacteria, as well as the need for more effective treatments for bacterial infections. Companies in the Baxdela market include Merck, Allergan, and Melinta Therapeutics. Show Less Read more